$63.45
00.00%
Pre-Market: 4:33 PM EDT
Comments
Loading...
Latest news for Biomarin Pharmaceutical (NASDAQ:BMRN) Stock
Biomarin Pharmaceutical Stock (NASDAQ: BMRN)
Categories: All
Monday, November 18, 2024
Friday, November 15, 2024
Wednesday, November 06, 2024
Tuesday, November 05, 2024
Wednesday, October 30, 2024
- BioMarin's Pipeline Faces Skepticism As Analyst Questions Future Growth
- Citigroup Maintains Neutral on Biomarin Pharm...
- Canaccord Genuity Maintains Hold on Biomarin ...
- Cantor Fitzgerald Maintains Overweight on Bio...
- JP Morgan Maintains Overweight on Biomarin Ph...
- RBC Capital Reiterates Sector Perform on Biom...
- Evercore ISI Group Maintains Outperform on Bi...
- In-Depth Examination Of 29 Analyst Recommendations For Biomarin Pharmaceutical
- UBS Maintains Buy on Biomarin Pharmaceutical,...
- Baird Maintains Neutral on Biomarin Pharmaceu...
- William Blair Downgrades Biomarin Pharmaceuti...
Tuesday, October 29, 2024
Monday, October 28, 2024
Tuesday, October 15, 2024
Thursday, October 10, 2024
Wednesday, October 09, 2024
Tuesday, October 08, 2024
Friday, October 04, 2024
Wednesday, September 25, 2024
Tuesday, September 24, 2024
Monday, September 23, 2024
Sunday, September 22, 2024
Wednesday, September 18, 2024
Tuesday, September 17, 2024
- Scotiabank Maintains Sector Perform on Biomar...
- Truist Securities Maintains Buy on Biomarin P...
- Wells Fargo Maintains Overweight on Biomarin ...
- RBC Capital Maintains Sector Perform on Bioma...
- GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
- B of A Securities Maintains Buy on Biomarin P...
- Stifel Maintains Buy on Biomarin Pharmaceutic...
- Bernstein Maintains Outperform on Biomarin Ph...